Triad Japan, a company supporting clinical trials, has released a report on its 'Online Seminar to Consider Schizophrenia Treatment and Options with Patients and Families.' The report was published on May 20, International Clinical Trials Day, as part of the company's Patient and Public Involvement (PPI) initiatives. The event featured lectures by specialists and a panel discussion with patients and family members. A post-seminar survey revealed that over 90% of participants gained a deeper understanding of treatments and clinical trials, with over 60% developing a more positive image of trials.

FACT BOX

  • Source: PR TIMES
  • Category: Press Release